BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7201342)

  • 21. A re-evaluation of trophoblastic diseases: syncytial endometritis, hydatidiform mole (benign and malignant) and choriocarcinoma.
    Villasanta U
    Indian Pract; 1966 May; 19(5):329-34. PubMed ID: 5938362
    [No Abstract]   [Full Text] [Related]  

  • 22. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of antineoplastic agents on the ovarian function in the patient after excision of hydatidiform mole].
    Nagai S; Abiko S; Nakaya K; Numata F; Hayashi N
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Feb; 19(2):179-82. PubMed ID: 5624225
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endometrial histological aspects after antiblastic treatment for vesicular mole].
    Albano V; Ragonese P
    Riv Anat Patol Oncol; 1969; 35():88-94. PubMed ID: 5408635
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
    Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
    J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramural molar pregnancy: a case report.
    Bhatia K; Bentick B
    J Reprod Med; 2004 Aug; 49(8):689-92. PubMed ID: 15457861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of chorioepithelioma with methotrexate].
    Mladenović D; Srbinović L; Prica R; Vućić V; Marković A
    Srp Arh Celok Lek; 1972 Jan; 100(1):76-84. PubMed ID: 5063781
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemoprophylaxis and chemotherapy of hydatidiform mole].
    Marsiletti GC
    Attual Ostet Ginecol; 1968; 1():52-75. PubMed ID: 5754750
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.
    Sharma S; Jagdev S; Coleman RE; Hancock BW; Lorigan PC
    Br J Cancer; 1999 Nov; 81(6):1037-41. PubMed ID: 10576662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of recurrent molar pregnancy.
    Federschneider JM; Goldstein DP; Berkowitz RS; Marean AR; Bernstein MR
    Obstet Gynecol; 1980 Apr; 55(4):457-9. PubMed ID: 7366903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Seroimmunological studies in vesicular mole].
    Montemagno U; Cardone A; Tolino A
    Arch Ostet Ginecol; 1974; 79(3-4):171-87. PubMed ID: 4471340
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Excretion of estrogens and pregnanediol in women with hydatid mole treated with methotrexate].
    Skriuchenkova VA; Ozerianskaia AL; Vinogradova EI
    Akush Ginekol (Mosk); 1973 Nov; 49(11):68-9. PubMed ID: 4799495
    [No Abstract]   [Full Text] [Related]  

  • 35. Live birth following treatment of post molar choriocarcinoma.
    Gurung G; Ojha N; Amatya A; Shrestha I; Kc N; Poudel S; Rana A
    Nepal Med Coll J; 2009 Mar; 11(1):66-8. PubMed ID: 19769244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate infusion in low-risk gestational trophoblastic disease.
    Wong LC; Ngan HY; Cheng DK; Ng TY
    Am J Obstet Gynecol; 2000 Dec; 183(6):1579-82. PubMed ID: 11120531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature.
    Bruchim I; Kidron D; Amiel A; Altaras M; Fejgin MD
    Gynecol Oncol; 2000 Apr; 77(1):197-202. PubMed ID: 10739712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triplet pregnancy with partial hydatidiform mole coexisting with two fetuses: a case report.
    Kim CH; Kim YH; Kim JW; Kim KM; Cho MK; Kim SM; Nam JH; Song TB
    J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):641-4. PubMed ID: 18840171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy in the treatment of undelivered hydatidiform mole. A study of 5 cases.
    Ma HK; Yip SK; Chun D
    J Obstet Gynaecol Br Commonw; 1971 Jan; 78(1):80-6. PubMed ID: 5104985
    [No Abstract]   [Full Text] [Related]  

  • 40. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.